Pfizer has lagged the broader market over the past year, and analysts remain cautious about its future outlook.
Zacks Investment Research on MSN
Investors heavily search Pfizer Inc. (PFE): Here is what you need to know
Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Pfizer Inc. (PFE) shares are trading higher on Tuesday, as the stock benefits from a price target increase at Cantor ...
PFE heads into Q4 earnings with strong oncology and Vyndaqel demand, but IRA headwinds, COVID declines and falling estimates ...
Overview: Pfizer stock is trading near $25.86 with moderate upside potential based on the forecast range of up to ...
Zacks Investment Research on MSN
Pfizer (PFE) exceeds market returns: Some facts to consider
Pfizer (PFE) closed the most recent trading day at $26.50, moving +2.4% from the previous trading session. The stock outperformed the S&P 500, which registered a daily gain of 0.41%. At the same time, ...
Pfizer Inc. (NYSE:PFE) is included among the 13 Best January Dividend Stocks to Invest in. Pfizer Inc. (NYSE:PFE) is among the drugmakers planning to raise prices on some medicines starting January 1.
Pfizer's (NYSE:PFE) stock is up by 4.7% over the past three months. Given that the markets usually pay for the long-term ...
All three of these stocks sport dividend yields above 6%.
Eli Lilly & Company LLY and Pfizer PFE are large-cap U.S. pharmaceutical leaders, each backed by diversified product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results